| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3849920 | American Journal of Kidney Diseases | 2010 | 13 Pages |
Abstract
Treatment with thiazolidinediones significantly decreases urinary albumin and protein excretion in patients with diabetes. This finding calls for clinical trials with hard renal outcomes to elucidate the potential benefits of thiazolidinediones on diabetic nephropathy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Pantelis A. MD, MSc, PhD, Panagiotis C. MD, MSc, Panagiotis I. MD, Athanasios N. MD, Anastasios N. MD, PhD,